z-logo
open-access-imgOpen Access
Phage therapy treatment of the coral pathogen V ibrio coralliilyticus
Author(s) -
Cohen Yossi,
Joseph Pollock F.,
Rosenberg Eugene,
Bourne David G.
Publication year - 2013
Publication title -
microbiologyopen
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 36
ISSN - 2045-8827
DOI - 10.1002/mbo3.52
Subject(s) - bacteriophage , phage therapy , pathogen , biology , microbiology and biotechnology , myoviridae , lytic cycle , outbreak , virology , marine bacteriophage , coral , virulence , virus , bacteria , ecology , escherichia coli , genetics , gene
V ibrio coralliilyticus is an important coral pathogen demonstrated to cause disease outbreaks worldwide. This study investigated the feasibility of applying bacteriophage therapy to treat the coral pathogen V . coralliilyticus . A specific bacteriophage for V . coralliilyticus strain P1 ( LMG23696 ), referred to here as bacteriophage YC , was isolated from the seawater above corals at N elly B ay, M agnetic I sland, central G reat B arrier R eef ( GBR ), the same location where the bacterium was first isolated. Bacteriophage YC was shown to be a lytic phage belonging to the M yoviridae family, with a rapid replication rate, high burst size, and high affinity to its host. By infecting its host bacterium, bacteriophage YC was able to prevent bacterial‐induced photosystem inhibition in pure cultures of S ymbiodinium , the photosymbiont partner of coral and a target for virulence factors produced by the bacterial pathogen. Phage therapy experiments using coral juveniles in microtiter plates as a model system revealed that bacteriophage YC was able to prevent V . coralliilyticus ‐induced photoinactivation and tissue lysis. These results demonstrate that bacteriophage YC has the potential to treat coral disease outbreaks caused by the bacterial pathogen V . coralliilyticus , making it a good candidate for phage therapy treatment of coral disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here